Abstract
Summary
Additional evidence has been cited to indicate that the sodium salt of p-aminobenzoic acid definitely reduced the mortality of experimental tsutsugamushi disease in gerbilles. A description has been given of the routine of administration of Na PAB which was successful. Data from other, less successful, routines have been reported to emphasize the importance of the mode of therapy in the evaluation of PABA in experimental infection with R. orientalls. A clinical trial of PABA in human tsutsugamushi disease is strongly recommended.
Get full access to this article
View all access options for this article.